This site is intended for healthcare professionals only
LoginRegister

Dermatology Dialogues

Oral tofacitinib, novel alternative treatment for resistant alopecia areata among children

Oral tofacitinib, novel alternative treatment for resistant alopecia areata among children

China: New research has demonstrated the safety and effectiveness of oral tofacitinib as a treatment option for pediatric alopecia areata (AA),...
View All

Latest News and Guidelines

Oral povorcitinib promising in extensive nonsegmental vitiligo at week 52 in Phase 2b clinical trial

Oral povorcitinib promising in extensive nonsegmental vitiligo at week 52 in Phase 2b clinical trial

JAK inhibitor use in skin conditions associated with elevated odds of the appearance of acne: JAMA

JAK inhibitor use in skin conditions associated with elevated odds of the appearance of acne: JAMA

Guselkumab efficacious among patients of psoriasis with skin of color

Guselkumab efficacious among patients of psoriasis with skin of color

Sanofi Gets CDSCO Panel Nod to Update Prescribing Information for Xenpozyme

Require additional efficacy data for Dupixent approval for chronic spontaneous urticaria: USFDA to...

Low serum desnutrin predicts insulin resistance in patients with vitiligo vulgaris

Low serum desnutrin predicts insulin resistance in patients with vitiligo vulgaris

Use of electric hair styling tools tied to burn injuries in children

Use of electric hair styling tools tied to burn injuries in children

View All
X